Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Leslie Andersen"'
Publikováno v:
Pulmonary Therapy. 2:91-114
An integrated analysis was performed using safety data from 18 randomized, parallel-group studies from the fluticasone furoate/vilanterol (FF/VI) GSK asthma clinical study program. Efficacy data from four pivotal studies were also analyzed. Data were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2069c1430d94b658fa83a48159069b4
https://doi.org/10.1007/s41030-016-0015-1
https://doi.org/10.1007/s41030-016-0015-1
Autor:
Eugene R. Bleecker, William W. Busse, Lucy Frith, Leslie Andersen, Jessica Lim, Jan Lötvall, Ashley Woodcock, Paul M. O'Byrne, Eric D. Bateman, Loretta Jacques
Publikováno v:
Thorax
Background Combination therapy with an inhaled corticosteroid (ICS) and long-acting β2 agonist (LABA) is recommended for patients with asthma symptomatic on ICS alone. However, there is ongoing debate regarding the risk-benefit ratio of using LABA i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b529c855e4a42afa8e6bd9e037d03ca3
https://doi.org/10.1136/thoraxjnl-2013-203600
https://doi.org/10.1136/thoraxjnl-2013-203600
Autor:
Ludovic Apoux, Jan Lötvall, Loretta Jacques, Eric D. Bateman, Wesley Hicks, Ashley Woodcock, Jodie Crawford, Paul M. O'Byrne, Eugene R. Bleecker, Leslie Andersen, William W. Busse
Publikováno v:
Thorax
Background The inhaled corticosteroid fluticasone furoate (FF) in combination with the long-acting β 2 agonist vilanterol (VI) is in development for asthma and chronic obstructive pulmonary disease. Objective To assess the safety and tolerability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d37b96bba3282164c2390f611b0534a1
https://doi.org/10.1136/thoraxjnl-2012-202606
https://doi.org/10.1136/thoraxjnl-2012-202606
Objective: We aimed to demonstrate non-inferiority of once-daily fluticasone furoate/vilanterol 100/25 µg (FF/VI) to twice-daily fluticasone propionate/salmeterol 250/50 µg (FP/SAL) in adults/adolescents with asthma well controlled on inhaled corti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c826fcaccdb18bccce8566995be013
Autor:
Steve Yancey, John J. Murray, Barbara A. Prillaman, James Wolfe, Paul Dorinsky, Leslie Andersen, John L. Stauffer, Steven M. Koenig
Publikováno v:
Respiratory Medicine. 102:665-673
Summary Rationale Little is known about the use of biomarkers in guiding treatment decisions in routine asthma management. The objective of this study was to determine whether adding a LABA to an ICS would control bronchial hyperresponsiveness (BHR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d65eddb5043f00c75bca5d7e1691aad
https://doi.org/10.1016/j.rmed.2007.12.023
https://doi.org/10.1016/j.rmed.2007.12.023
Publikováno v:
Chest. 152:A186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecd17e56d702b0c0d1ae5ce620d078ff
https://doi.org/10.1016/j.chest.2017.08.217
https://doi.org/10.1016/j.chest.2017.08.217
Autor:
Hector Ortega, Shu-Yen Ho, Leslie Andersen, Heather M. Edin, Catherine Scott-Wilson, Lynne Schoaf
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 102(4)
Background Current asthma guidelines emphasize domains of impairment and risk for assessing severity and control, noting the need to consider separately the effects of asthma on asthma quality of life and functional capacity. Proper treatment to cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0cf541e5db553e348fa1ffccf80c112
https://pubmed.ncbi.nlm.nih.gov/19441604
https://pubmed.ncbi.nlm.nih.gov/19441604
Publikováno v:
Journal of clinical gastroenterology. 41(3)
Whether patients with functional chest pain have an esophageal or overlapping functional disorder of the gut is unclear. We investigated the prevalence of functional gastrointestinal disorders in patients with functional chest pain.One hundred patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c911590336d70306c9edf4e37576755d
https://pubmed.ncbi.nlm.nih.gov/17426464
https://pubmed.ncbi.nlm.nih.gov/17426464
Autor:
William W. Busse, Leslie Andersen
Publikováno v:
Thorax. 68:1165.2-1166
We thank Dr Lipworth for his response to our article on the safety and tolerability of fluticasone furoate/vilanterol (FF/VI) combination in asthma,1 in which he specifically discusses effects on urinary cortisol. We acknowledge the limitations of ur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd3aa5effb3263307fe9bdcca12447a
https://doi.org/10.1136/thoraxjnl-2013-203992
https://doi.org/10.1136/thoraxjnl-2013-203992
Autor:
Morales, Leslie Andersen
Publikováno v:
Faces; Jan2003, Vol. 19 Issue 5, p34, 2p, 2 Color Photographs